AAV-mediated delivery of a novel anti-BACE1 VHH reduces Abeta in an Alzheimer's disease mouse model

被引：0
|
作者：
Rincon, M. Y. [1 ,2 ]
Zhou, L. [1 ,2 ]
Marneffe, C. [1 ,2 ]
Voytyuk, I. [1 ,2 ]
Wouters, Y. [1 ,2 ]
Dewilde, M. [1 ,2 ]
Duque, S. I. [1 ]
Vincke, C. [3 ]
Levites, Y. [4 ]
Golde, T. E. [4 ]
Muyldermans, S. [3 ]
De Strooper, B. [1 ,2 ,6 ]
Holt, M. G. [1 ,2 ,5 ]
机构：
[1] KU Leuven, VIB, Ctr Brain & Dis Res, B-3000 Leuven, Belgium
[2] KU Leuven, Dept Neurosci, B-3000 Leuven, Belgium
[3] Vrije Univ Brussel, Lab Cellular & Mol Immunol, Pl Laan 2, B-1050 Brussels, Belgium
[4] Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Dept Neurosci,McKnight Brain Inst, Gainesville, FL 32610 USA
[5] Leuven Brain Inst, B-3000 Leuven, Belgium
[6] UCL, UK Dementia Res Inst, Cruciform Bldg Gower St, London WC1E 6BT, England
来源：
HUMAN GENE THERAPY | 2019年 / 30卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P258
引用
收藏
页码：A95 / A95
页数：1
相关论文
共 50 条
  • [1] AAV-mediated delivery of an anti-BACE1 VHH alleviates pathology in an Alzheimer's disease model
    Marino, Marika
    Zhou, Lujia
    Rincon, Melvin Y.
    Callaerts-Vegh, Zsuzsanna
    Verhaert, Jens
    Wahis, Jerome
    Creemers, Eline
    Yshii, Lidia
    Wierda, Keimpe
    Saito, Takashi
    Marneffe, Catherine
    Voytyuk, Iryna
    Wouters, Yessica
    Dewilde, Maarten
    Duque, Sandra, I
    Vincke, Cecile
    Levites, Yona
    Golde, Todd E.
    Saido, Takaomi C.
    Muyldermans, Serge
    Liston, Adrian
    De Strooper, Bart
    Holt, Matthew G.
    [J]. EMBO MOLECULAR MEDICINE, 2022, 14 (04)
  • [2] Overexpression of β-Secretase 1 (BACE1) by AAV-mediated Gene Delivery Provides Protection in a Mouse Model of AMD
    Qi, Xiaoping
    Boehm, Skyler
    Mitter, Sayak
    Quigley, Judith L.
    Silva, Juliete A. F.
    Francelin, Carolina
    Grant, Maria B.
    Boulton, Michael E.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [3] AAV-Mediated APOE Gene Silencing for Alzheimer's Disease
    Hentschel, Lisa
    Oudshoorn-Dickmann, Maroeska
    Wattimury, Hendrina
    Boggiani, Lorenzo
    Moreno, Fiona
    Tripathi, Shrijana
    Pereira, Ines Lopes
    Nogueira, Ana
    Peris, Sara Gimeno
    Villamil, Javier
    Spronck, Lisa
    Bosma, Bas
    Kusuma, Angga
    Dobrynin, Greg
    Liu, Ying Poi
    [J]. MOLECULAR THERAPY, 2022, 30 (04) : 433 - 434
  • [4] Natural Compounds with Anti-BACE1 Activity as Promising Therapeutic Drugs for Treating Alzheimer's Disease
    Naushad, Mehjabeen
    Durairajan, Siva Sundara Kumar
    Bera, Amal Kanti
    Senapati, Sanjib
    Li, Min
    [J]. PLANTA MEDICA, 2019, 85 (17) : 1316 - 1325
  • [5] AAV-mediated delivery of SMN1 in a mouse model of spinal muscular atrophy
    Lattanzi, A.
    Armbruster, N.
    Jeavons, M.
    Van Witthenberghe, L.
    Marais, T.
    Martin, S.
    Vignaud, A.
    Voit, T.
    Mavilio, F.
    Bello, A. Buj
    Barkats, M.
    [J]. HUMAN GENE THERAPY, 2014, 25 (11) : A43 - A43
  • [6] Delivery of BACE1 siRNA mediated by TARBP-BTP fusion protein reduces β-amyloid deposits in a transgenic mouse model of Alzheimer's disease
    Haroon, Mohamed Mohamed
    Saba, Kamal
    Boddedda, Venkata Harshavardhan
    Kumar, Jerald Mahesh
    Patel, Anant Bahadur
    Gopal, Vijaya
    [J]. JOURNAL OF BIOSCIENCES, 2019, 44 (01)
  • [7] Delivery of BACE1 siRNA mediated by TARBP-BTP fusion protein reduces β-amyloid deposits in a transgenic mouse model of Alzheimer’s disease
    Mohamed Mohamed Haroon
    Kamal Saba
    Venkata Harshavardhan Boddedda
    Jerald Mahesh Kumar
    Anant Bahadur Patel
    Vijaya Gopal
    [J]. Journal of Biosciences, 2019, 44
  • [8] AAV-mediated CYP46A1 delivery is beneficial in Alzheimer's disease models: towards a clinical application
    Alves, S.
    Michaelsen-Preusse, K.
    Audrain, M.
    Aron-Badin, R.
    Lamaziere, A.
    Fol, R.
    Braudeau, J.
    Despres, G.
    Fouquet, F.
    Pradier, L.
    Delatour, B.
    Korte, M.
    Hantraye, P.
    Aubourg, P.
    Cartier, N.
    [J]. HUMAN GENE THERAPY, 2016, 27 (11) : A47 - A47
  • [9] The selective BACE1 inhibitor VIa reduces Aβ production in a mouse model of Alzheimer's disease
    Cheng, Xiao-rui
    Zhou, Yu
    Gu, Wei
    Nie, Ai-hua
    Cheng, Jun-ping
    Zhou, Wen-xia
    Zhang, Yong-xiang
    [J]. FASEB JOURNAL, 2014, 28 (01):
  • [10] Improvement of neuropathological abnormalities in a Huntington's disease model by recombinant AAV-mediated delivery of shRNA
    Machida, Y
    Okada, T
    Kurosawa, M
    Oyama, F
    Ozawa, K
    Nukina, N
    [J]. JOURNAL OF GENE MEDICINE, 2006, 8 (03): : 392 - 392
12345